首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Searching for a successful HDL-based treatment strategy
Authors:Srinivasa T Reddy  Mohamad Navab  GM Anantharamaiah  Alan M Fogelman
Institution:1. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA;2. Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA;3. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA;4. Department of Medicine, University of Alabama at Birmingham, AL 35294, USA
Abstract:Despite strong evidence that HDL-cholesterol levels predict atherosclerotic events in a population, attempts at using an HDL-based treatment strategy have not yet been successful. Most of the efforts to date have focused on raising plasma HDL-cholesterol levels. This brief review focuses on a different strategy, which is based on the use of 18-amino acid apoA-I mimetic peptides. The story of these peptides spans decades and illustrates the remarkable complexity of HDL-based treatment strategies, but suggests that such a strategy may still be successful.
Keywords:ApoA-I  apolipoprotein A-I  CHD  coronary heart disease  EV  transgenic tomatoes constructed with an empty vector  FGF  Fibroblast Growth Factor  FGFR1  FGF Receptor 1  FPLC  fast performance liquid chromatography  HDL  high density lipoprotein  HIF-1α  hypoxia-inducible factor-1α  LDL  low density lipoprotein  LDLR&minus  /&minus    LDL receptor null  LPA  lysophosphatidic acid  MCP-1  Monocyte chemoattractant protein 1  MnSOD  manganese superoxide dismutase  SQ  subcutaneous injection  SR-A  scavenger receptor A  Tg6F  transgenic 6F tomatoes  TLR  toll-like receptor  VEGF  Vascular Endothelial Growth Factor  VEGFR2  VEGF Receptor 2  WD  Western diet
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号